{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:16:52Z","timestamp":1780568212971,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejogrb.2013.09.039","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T08:35:46Z","timestamp":1381394146000},"page":"307-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hyperandrogenic women treated with a continuous-regimen oral contraceptive"],"prefix":"10.1016","volume":"171","author":[{"given":"Salvatore","family":"Caruso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Malandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Lo","family":"Presti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.09.039_bib0005","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/j.1743-6109.2009.01529.x","article-title":"Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate","volume":"6","author":"Caruso","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0889-8529(03)00044-6","article-title":"Assessment and management of anovulatory infertility in polycystic ovary syndrome","volume":"32","author":"Franks","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0015","first-page":"53","article-title":"Diagnostic procedures in polycystic ovary syndrome","volume":"27","author":"Hahn","year":"2003","journal-title":"J Lab Med"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2006.03.003","article-title":"Treatment of hirsutism and acne in hyperandrogenism","volume":"20","author":"Moghetti","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0025","first-page":"119","article-title":"Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary","volume":"40","author":"Vrbikova","year":"2006","journal-title":"Endocr Regul"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/09513590802454943","article-title":"Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3mg and ethynilestradiol 30 microg and chlormadinone 2mg on skin and hormonal hyperandrogenic manifestations","volume":"24","author":"Lello","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/1362518042000221508","article-title":"The role of combined oral contraceptives in the management of acne and seborrhea","volume":"9","author":"del Marmol","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2011.02.013","article-title":"Current issues and available options in combined hormonal contraception","volume":"84","author":"Bitzera","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0045","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1743-6109.2011.02208.x","article-title":"Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3mg drospirenone and 20\u03bcg ethinyl estradiol","volume":"8","author":"Caruso","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0050","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1111\/j.1743-6109.2011.02409.x","article-title":"Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V\/DNG) oral contraceptive on the quality of sexual life","volume":"8","author":"Caruso","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2010.11.004","article-title":"The evolution of combined oral contraception: improving the risk-to-benefit ratio","volume":"84","author":"Burkman","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0030-1248139","article-title":"Recent innovations in oral contraception","volume":"28","author":"Cremer","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.contraception.2010.04.002","article-title":"Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome","volume":"82","author":"De Leo","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensusion diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ARSM-sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0080","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0090","first-page":"299","article-title":"Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol","volume":"7","author":"Cremoncini","year":"1976","journal-title":"Acta Eur Fertil"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2010.12.027","article-title":"Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20\u03bcg plus drospirenone 3mg administered in a 24\/4 regimen: a pooled analysis","volume":"155","author":"Koltun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.contraception.2011.03.002","article-title":"A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24\/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21\/7 combined oral contraceptive in the treatment of hirsutism","volume":"84","author":"Oner","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13625180600983082","article-title":"Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome","volume":"12","author":"Pehlivanov","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1783\/1471189041261636","article-title":"An observational study of Yasmin in the management of women with polycystic ovary syndrome","volume":"30","author":"Palep-Singh","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome","volume":"98","author":"Bhattacharya","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0125","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Bernard","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0015-0282(16)58028-5","article-title":"Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease","volume":"65","author":"Ciotta","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0135","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0015-0282(16)57174-X","article-title":"Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients","volume":"62","author":"Ciotta","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)57727-9","article-title":"Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism","volume":"64","author":"Ciotta","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jcem.85.4.6560","article-title":"Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome","volume":"85","author":"De Leo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/01443610601113797","article-title":"Therapeutic options in the polycyctic ovary syndrome","volume":"27","author":"Bhathena","year":"2007","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00128071-200001020-00003","article-title":"Management of hirsutism","volume":"1","author":"Falsetti","year":"2000","journal-title":"Am J Clin Dermat"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1576\/toag.6.2.66.26980","article-title":"The current understanding of polycystic ovary syndrome","volume":"6","author":"Balen","year":"2004","journal-title":"Obstetrician Gynaecologist"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0165","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/humrep\/del185","article-title":"Metformin treatment is effective in obese teenage girls with PCOS","volume":"21","author":"De Leo","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0170","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0175","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception","volume":"3","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2013.09.039_bib0180","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1743-6109.2012.03004.x","article-title":"Quality of sexual life of women on oral contraceptive continued-regimen: pilot study","volume":"10","author":"Caruso","year":"2013","journal-title":"J Sex Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151300496X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151300496X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:15Z","timestamp":1759555815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151300496X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S030121151300496X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.09.039","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperandrogenic women treated with a continuous-regimen oral contraceptive","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}